Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain

Inclusion Criteria: * Patient is eligible for SCS therapy according to the Algovita SCS system Indications for Use statement * Patient had successful Algovita SCS system stimulation trial with an Algovita SCS system and will be implanted with a permanent Algovita SCS system; prior approval must be obtained from the Sponsor if another SCS system was used for the stimulation trial * Patient is willing and able to sign an IRB/EC approved informed consent, and in the United States, a Privacy Protection Authorization, as required Exclusion Criteria: * Patient is contraindicated for an Algovita SCS system * Patient has a cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments * Patient has a life expectancy of less than 2 years * Patient is participating in another clinical study that would confound data analysis * Patient has a coexisting pain condition that might confound pain ratings